Related Experiment Video
Updated: Aug 28, 2026
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Vitamin D and Infection Risk in Patients with Short Bowel Syndrome and Intestinal Failure
Hsi-Ming Liu1, Ya-Hui Tsai2, Chao-Ling Yao3
1Department of Surgery, Far Eastern Memorial Hospital, Taiwan.
Purpose:
Patients with short bowel syndrome (SBS) and intestinal failure (IF) are highly susceptible to micronutrient deficiencies and recurrent infections. Vitamin D plays an important role in immune modulation and has been linked to infection outcomes in other high-risk populations, yet its relevance in SBS/IF remains unclear. This study evaluated the effectiveness of vitamin D supplementation and the association between serum 25-hydroxyvitamin D [25(OH)D] levels and infection risk in SBS/IF patients.
Method:
In this single-center retrospective cohort study, 23 SBS/IF patients (8 pediatric, 34.8%) followed between November 2022 and November 2025 were included. Baseline 25(OH)D levels showed universal insufficiency, with 78.3% classified as deficient (<20 ng/mL). Changes in 25(OH)D levels at 6-12 months were compared between patients with and without supplementation using ANCOVA. The association between serial 25(OH)D levels and recurrent infection events was analyzed using a time-dependent Cox model with person-mean centering.
Results:
Vitamin D supplementation resulted in significantly greater increases in serum 25(OH)D compared with non-supplementation (mean change +15.61 vs. -0.40 ng/mL; ANCOVA F = 18.33, p = 0.001). During follow-up, 26 infection events occurred. Higher within-individual 25(OH)D levels were associated with a reduced hazard of infection (HR 0.92 per 1 ng/mL increase; 95% CI 0.869-0.976; p = 0.005).
Conclusion:
Vitamin D supplementation effectively improves vitamin D levels in SBS/IF patients. Higher 25(OH)D levels were associated with lower infection hazard, suggesting vitamin D status may represent a modifiable factor related to infection risk in this population.
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:30Vitamins
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:23Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:26Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...